AMETEK Posts Record $2.0B Q4 Revenues, 7% EPS Growth to $2.01, Guides 2026 EPS $7.87-8.07

AMEAME

AMETEK posted record Q4 sales of $2.0B, up 13% year-over-year, with adjusted EPS of $2.01 (up 7%) and free cash flow of $527 million. Full-year 2025 sales rose 7% to $7.4B with adjusted EPS of $7.43 (+9%); 2026 guidance targets mid-high single-digit growth and EPS of $7.87-8.07.

1. Record Fourth Quarter Financial Results

AMETEK reported fourth quarter sales of $2.0 billion, marking a 13% increase from the prior year. On a GAAP basis, diluted earnings per share reached a record $1.73, while adjusted earnings per share rose 7% year-over-year to $2.01. These adjusted results exclude $17.6 million of pre-tax acquisition-related costs and $0.22 per share of non-cash amortization expenses. The performance reflects broad-based strength in both operating segments and disciplined cost management.

2. Strong Operating Income and Cash Generation

GAAP operating income for the quarter was $505.5 million, up 8% versus the fourth quarter of 2024, while adjusted operating income climbed 12% to $523.0 million. Operating cash flow reached a record $584.3 million and free cash flow was $527.3 million, representing a free cash flow to net income conversion of 132%. These metrics underscore AMETEK’s operational excellence and ability to convert revenue growth into robust cash generation.

3. Segment Performance Drives Growth

The Electronic Instruments Group delivered quarterly sales of $1.37 billion, up 13%, with adjusted operating income of $413.7 million, a 7% increase and 50 basis points of core margin expansion. The Electromechanical Group achieved sales of $628.9 million, rising 15%, and operating income surged 28% to $142.5 million, boosting segment margins by 240 basis points to 22.7%. Both segments benefited from strong organic demand and contributions from recent acquisitions.

4. 2026 Outlook and Strategic Priorities

For full year 2026, AMETEK forecasts sales growth in the mid to high single-digit range and adjusted earnings per share between $7.87 and $8.07, representing 6% to 9% growth. The company enters the year with a record backlog, improving end-market conditions and financial flexibility to pursue both organic initiatives and strategic acquisitions. First quarter sales are expected to increase approximately 10%, with adjusted EPS of $1.85 to $1.90, up 6% to 9% year-over-year.

Sources

SZZP